Montana § 50-12-108 Disciplinary Action Prohibited

Montana Statutes

§ 50-12-108 — Disciplinary Action Prohibited

Montana § 50-12-108

Title 50HEALTH AND SAFETY

Ch. 12TREATMENTS FOR CHRONIC OR TERMINAL ILLNESS

Part 1Right to Try Act

This text of Montana § 50-12-108 (Disciplinary Action Prohibited) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 50-12-108 (2026).

Text

50-12-108 . Disciplinary action prohibited.

(1)A licensing board may not revoke, fail to renew, suspend, or take any action against a license issued under Title 37 to a health care provider based solely on the health care provider's recommendations to a patient regarding access to or provision of an experimental treatment.

(2)The department of public health and human services may not take action against:

(a)a health care provider's medicare certification based solely on the health care provider's recommendation that a patient have access to an experimental treatment; or

(b)a health care facility's license based solely on the facility's recommendation to a patient regarding access to or the provision of an experimental treatment in accordance with this part.

Free access — add to your briefcase to read the full text and ask questions with AI

50-12-108 . Disciplinary action prohibited. (1) A licensing board may not revoke, fail to renew, suspend, or take any action against a license issued under Title 37 to a health care provider based solely on the health care provider's recommendations to a patient regarding access to or provision of an experimental treatment.
(2) The department of public health and human services may not take action against:
(a) a health care provider's medicare certification based solely on the health care provider's recommendation that a patient have access to an experimental treatment; or
(b) a health care facility's license based solely on the facility's recommendation to a patient regarding access to or the provision of an experimental treatment in accordance with this part.